Home / About LSDs / Tay-Sachs Disease
Tay-Sachs Disease: Symptoms, Treatment and Support in India
Tay-Sachs disease is a rare inherited disorder in which a fatty substance builds up in the nerve cells of the brain and spinal cord. There is no cure yet, but good supportive care, genetic counselling and family support make a real difference.
Key facts
Cause
Deficiency of the enzyme beta-hexosaminidase A (HEXA gene)
Inheritance
Autosomal recessive
Mainly affects
Nerve cells in the brain and spinal cord
Usual onset
At 3 to 6 months of age (infantile form)
Treatment
Supportive and palliative care; new therapies are being studied
Overview
What is Tay-Sachs disease?
Tay-Sachs disease is a rare genetic disorder that progressively destroys nerve cells in the brain and spinal cord. It is caused by a deficiency of the enzyme beta-hexosaminidase A, which normally breaks down a fatty substance called GM2 ganglioside.
Without the enzyme, GM2 ganglioside builds up to harmful levels in nerve cells. In the most common, infantile form, babies develop normally for the first few months, then gradually lose skills such as turning over, sitting and crawling.
Tay-Sachs disease belongs to a group called the GM2 gangliosidoses, which also includes the closely related Sandhoff disease.
Video: Tay-Sachs disease explained (credit: Osmosis)
Tay-Sachs disease in India
Tay-Sachs disease is rare in the general population but more common in some communities, often because of shared ancestry or marriage between close relatives (consanguinity). Indian studies have identified it in families from many states, and a shared gene change has been reported in several families from Gujarat.
Because there is no cure yet, carrier testing and genetic counselling are especially important. Families with an affected child can have prenatal or pre-implantation genetic testing in future pregnancies.
Did you know?
Carrier screening has reduced Tay-Sachs births by more than 90% in communities where it was once common.
A blood test can show whether a person carries the gene change.
Types of Tay-Sachs disease
The types are named after the age at which symptoms begin. The later they begin, the more slowly the disease usually progresses.
Infantile (classic) Tay-Sachs
The most common and most severe form. Symptoms begin at 3 to 6 months of age, with loss of skills, an exaggerated startle response to noise, seizures, and loss of vision and hearing. Most children live only into early childhood.
Juvenile Tay-Sachs
Symptoms usually begin between the ages of 2 and 10, with clumsiness, speech difficulties, learning problems and seizures. The disease progresses more slowly, and children often live into late childhood or the teenage years.
Late-onset Tay-Sachs
A milder form that begins in adolescence or adulthood. It causes muscle weakness, unsteadiness, tremors, slurred speech and sometimes mental health problems. It does not always shorten life.
Related condition
Sandhoff disease
Sandhoff disease is a closely related GM2 gangliosidosis. It is caused by changes in the HEXB gene, which lead to a deficiency of two enzymes, beta-hexosaminidase A and B. As in Tay-Sachs disease, GM2 ganglioside builds up in nerve cells.
Its symptoms are very similar to those of Tay-Sachs disease, and the infantile form, which begins at 3 to 6 months of age, is the most common. Some babies with Sandhoff disease also have an enlarged liver and spleen. Rarer juvenile and adult forms progress more slowly.
Sandhoff disease is reported in Indian children. Care, genetic counselling and family support are the same as for Tay-Sachs disease, and clinical trials for GM2 gangliosidosis usually include both conditions.
At a glance
Cause
Deficiency of beta-hexosaminidase A and B (HEXB gene)
Inheritance
Autosomal recessive
How it is diagnosed
A blood test shows low activity of both hexosaminidase A and B (in Tay-Sachs disease only A is low). A genetic test confirms it.
Treatment
Supportive and palliative care; new therapies are being studied
Signs and symptoms
Symptoms of Tay-Sachs disease
In the infantile form, symptoms usually appear between 3 and 6 months of age and may include:
- Loss of skills already learned, such as rolling over, sitting or crawling
- An exaggerated startle response to loud noises
- Weak, floppy muscles, later followed by stiffness
- A cherry-red spot at the back of the eye, seen in an eye examination
- Seizures, and gradual loss of vision and hearing
- Difficulty swallowing and frequent chest infections
When to see a doctor
Consult a doctor, ideally a paediatric neurologist or geneticist, if your child has:
- Loss of skills already learned, or slowing development
- An unusually strong startle response to sound
- Reduced eye contact or vision problems
- Seizures
An eye doctor can often see the cherry-red spot that is a key clue to Tay-Sachs disease and related disorders.
Causes
What causes Tay-Sachs disease?
Tay-Sachs disease is caused by changes (mutations) in the HEXA gene, which gives the body instructions to make part of the enzyme beta-hexosaminidase A.
When the enzyme is missing, GM2 ganglioside builds up in nerve cells of the brain and spinal cord, and the cells gradually stop working and die. People with some remaining enzyme activity tend to have the later-onset forms.
How it is inherited
- It is inherited in an autosomal recessive pattern.
- Parents of an affected child are usually healthy carriers of one faulty copy of the gene.
- When both parents are carriers, each pregnancy has a 1 in 4 (25%) chance of an affected child.
- Carrier testing before pregnancy can identify couples at risk.
How is Tay-Sachs disease diagnosed?
A blood test can confirm Tay-Sachs disease, and similar tests can identify carriers.
01
Enzyme test
A blood test measures beta-hexosaminidase A activity. Very low or absent activity confirms Tay-Sachs disease.
02
Genetic test
Identifies the changes in the HEXA gene. It helps confirm the diagnosis, test relatives and plan future pregnancies.
03
Eye examination
An eye doctor looks for a cherry-red spot at the back of the eye, which is seen in most babies with infantile Tay-Sachs disease.
04
Prenatal and carrier testing
Couples who are both carriers can have testing during pregnancy (chorionic villus sampling or amniocentesis), or pre-implantation genetic testing with IVF.
Care and treatment for Tay-Sachs disease
There is no cure and no approved disease-specific treatment yet. Care focuses on keeping the child comfortable and supporting the family.
Supportive care
A team of specialists helps manage symptoms as the disease progresses.
This can include
- Medicines to control seizures
- Feeding support, including feeding tubes
- Chest physiotherapy and treatment of infections
- Physiotherapy to ease stiffness and keep joints comfortable
Palliative care and family support
Palliative care focuses on comfort and quality of life for the child and the whole family. It can be given alongside other care, at home or in hospital, and includes emotional support for parents and siblings.
Research and clinical trials
Gene therapy, substrate reduction therapy and other approaches are being studied. To find ongoing or upcoming clinical trials in India, visit ClinicalTrials.gov.
Genetic counselling is an important part of care. It helps families understand the chance of Tay-Sachs disease in future children and the testing options available.
Clinical trials and studies in India
Studies of Tay-Sachs disease that are recruiting, or about to recruit, in India. This list updates automatically every day.
- A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease, GM1 Gangliosidosis or GM2 GangliosidosisSites in India: Ernākulam, New Delhi, Jaipur, Vellore
Last checked 11 November 2026 on ClinicalTrials.gov. Always talk to your doctor before joining a study.
Accessing treatment in India
Getting care and support
Caring for a child with Tay-Sachs disease is demanding, emotionally and financially. These are the main sources of help.
Government support (NPRD)
The National Policy for Rare Diseases supports diagnosis, genetic counselling and care for rare diseases at designated Centres of Excellence (COEs). Ask your COE what help is available for your family.
- Visit your nearest COE with all medical reports
- Ask about genetic counselling and testing for the family
- Financial assistance is subject to approval
Other sources of help
- State government health schemes
- Corporate social responsibility (CSR) funding
- Crowdfunding through the government rare disease portal
- Palliative care services near you
How LSDSS helps
- Connects patients with COEs and specialists
- Guides families through funding applications
- Shares updates on support programmes
- Brings patients and caregivers together
Frequently asked questions
Answers to common questions about Tay-Sachs disease.
Still have a question?
A rare inherited disorder in which a deficiency of the enzyme beta-hexosaminidase A causes a fatty substance, GM2 ganglioside, to build up in nerve cells of the brain and spinal cord, gradually destroying them.
In the infantile form, symptoms usually start between 3 and 6 months of age. They include slowing development and loss of skills such as rolling over and sitting, an exaggerated startle response to noise, floppy muscles, a cherry-red spot in the eye, seizures, and loss of vision and hearing.
In the infantile form, most children live only until about the age of 4 or 5. Children with the juvenile form often live into late childhood or the teenage years. People with late-onset Tay-Sachs disease may have a normal or near-normal lifespan.
Not yet. There is no approved treatment that stops the disease, but supportive and palliative care can ease symptoms. Gene therapy and other treatments are being studied in clinical trials.
A carrier has one changed copy of the HEXA gene and one working copy. Carriers are healthy and usually do not know they carry the gene. When both parents are carriers, each pregnancy has a 1 in 4 chance of a child with Tay-Sachs disease, a 1 in 2 chance of a child who is a carrier, and a 1 in 4 chance of a child who is neither.
Because it is genetic, it cannot be prevented once a child is affected. Carrier testing, genetic counselling, and prenatal or pre-implantation genetic testing help couples at risk make informed choices.
Both are GM2 gangliosidoses and cause very similar symptoms. Tay-Sachs disease is caused by changes in the HEXA gene and a lack of the enzyme hexosaminidase A. Sandhoff disease is caused by changes in the HEXB gene, which lead to a lack of both hexosaminidase A and B. An enzyme blood test can tell them apart.
First, visit your nearest Centre of Excellence (COE) with all medical reports to be evaluated and to get genetic counselling. Second, register with LSDSS for support and to connect with other families.
Other lysosomal storage disorders
LSDSS supports patients and families living with all lysosomal storage disorders.
Sulfatides build up and damage the protective covering of nerves.
A fatty substance builds up in nerve cells and, in babies, in other organs and bones.
Waste material builds up in nerve cells, causing seizures and loss of vision.
Caring for a child with Tay-Sachs disease?
Register with LSDSS for guidance, support and the latest updates. You are not alone.
This page is for general information and awareness only. It does not replace advice from a qualified doctor. Last reviewed: November 2026.